Eli Lilly and Company (LLY)
NYSE: LLY · IEX Real-Time Price · USD
733.51
+8.64 (1.19%)
At close: Apr 26, 2024, 4:00 PM
733.50
-0.01 (0.00%)
After-hours: Apr 26, 2024, 7:59 PM EDT

Eli Lilly Revenue

In the year 2023, Eli Lilly had annual revenue of $34.12B with 19.56% growth. Revenue in the quarter ending December 31, 2023 was $9.35B with 28.10% year-over-year growth.

Revenue (ttm)
$34.12B
Revenue Growth
+19.56%
P/S Ratio
20.44
Revenue / Employee
$793,584
Employees
43,000
Market Cap
697.40B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202334.12B5.58B19.56%
Dec 31, 202228.54B223.00M0.79%
Dec 31, 202128.32B3.78B15.40%
Dec 31, 202024.54B2.22B9.95%
Dec 31, 201922.32B826.20M3.84%
Dec 31, 201821.49B1.52B7.61%
Dec 31, 201719.97B-1.25B-5.88%
Dec 31, 201621.22B1.26B6.33%
Dec 31, 201519.96B343.10M1.75%
Dec 31, 201419.62B-3.50B-15.13%
Dec 31, 201323.11B509.70M2.25%
Dec 31, 201222.60B-1.68B-6.93%
Dec 31, 201124.29B1.21B5.25%
Dec 31, 201023.08B1.24B5.68%
Dec 31, 200921.84B1.46B7.19%
Dec 31, 200820.37B1.74B9.33%
Dec 31, 200718.63B2.94B18.75%
Dec 31, 200615.69B1.05B7.14%
Dec 31, 200514.65B787.40M5.68%
Dec 31, 200413.86B1.28B10.14%
Dec 31, 200312.58B1.51B13.59%
Dec 31, 200211.08B-465.00M-4.03%
Dec 31, 200111.54B680.30M6.26%
Dec 31, 200010.86B859.30M8.59%
Dec 31, 199910.00B766.10M8.29%
Dec 31, 19989.24B1.25B15.64%
Dec 31, 19977.99B989.40M14.14%
Dec 31, 19967.00B234.50M3.47%
Dec 31, 19956.76B1.05B18.42%
Dec 31, 19945.71B513.10M9.87%
Dec 31, 19935.20B235.40M4.74%
Dec 31, 19924.96B-762.60M-13.32%
Dec 31, 19915.73B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 371.62B
Johnson & Johnson 85.16B
Merck & Co. 60.12B
AbbVie 54.32B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.86B
Abbott Laboratories 40.11B
Revenue Rankings